Elsevier

Ageing Research Reviews

Volume 64, December 2020, 101049
Ageing Research Reviews

Review
Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories

https://doi.org/10.1016/j.arr.2020.101049Get rights and content

Highlights

  • Oligomeric Aβ42 is critically involved in HNE formation in AD and MCI brain.

  • Lipid peroxidation product HNE binds to AD brain proteins, causing neuronal death.

  • Among HNE-altered functions in AD brain are glycolysis & voltage-gated ion-channels.

  • Butterfield & Mattson laboratories each provided greater understanding of AD, synergy.

Abstract

Brains from persons with Alzheimer disease (AD) and its earlier stage, amnestic mild cognitive impairment (MCI), exhibit high levels of oxidative damage, including that to phospholipids. One type of oxidative damage is lipid peroxidation, the most important index of which is protein-bound 4-hydroxy-2-trans-nonenal (HNE). This highly reactive alkenal changes the conformations and lowers the activities of brain proteins to which HNE is covalently bound. Evidence exists that suggests that lipid peroxidation is the first type of oxidative damage associated with amyloid β-peptide (Aβ), a 38-42 amino acid peptide that is highly neurotoxic and critical to the pathophysiology of AD. The Butterfield laboratory is one of, if not the, first research group to show that Aβ42 oligomers led to lipid peroxidation and to demonstrate this modification in brains of subjects with AD and MCI. The Mattson laboratory, particularly when Dr. Mattson was a faculty member at the University of Kentucky, also showed evidence for lipid peroxidation associated with Aβ peptides, mostly in in vitro systems. Consequently, there is synergy between our two laboratories. Since this special tribute issue of Aging Research Reviews is dedicated to the career of Dr. Mattson, a review of some aspects of this synergy of lipid peroxidation and its relevance to AD, as well as the role of lipid peroxidation in the progression of this dementing disorder seems germane. Accordingly, this review outlines some of the individual and/or complementary research on lipid peroxidation related to AD published from our two laboratories either separately or jointly.

Introduction

This review focuses on lipid peroxidation in brains of persons with Alzheimer disease (AD) and its earlier stage, amnestic mild cognitive impairment (MCI). More specifically, this review focuses on the lipid peroxidation product, 4-hydroxy-2-nonenal (HNE), and the changes in structure and function of brain proteins in AD and MCI relative to those control brains that this highly reactive and neurotoxic alkenal engenders. This review also focuses on the roles of HNE associated with amyloid β-peptide (Aβ) oligomers in AD-relevant in vitro, ex vivo, and in vivo systems reported by the Butterfield and/or Mattson laboratories. This emphasis is apropos given that this paper is part of a Special Issue of the journal, Ageing Research Reviews honoring Mark P. Mattson for his distinguished scientific career in these fields.

Section snippets

Epidemiology, Pathophysiology, and Pathogenesis

An authoritative pathological exposition of AD and MCI has been reported by Nelson and Markesbery (Nelson et al., 2009; Markesbery, 2007a,b; Markesbery, 2010) or other neuropathologists (Landau and Frosch, 2014; Malek-Ahmadi et al., 2018). The sixth leading cause of death in the United States, AD presents as a disorder associated with progressive loss of cognitive function finally ending in dementia. In later stages of AD, aphasia often occurs. AD patients often are restless, unsettled, and

Aβ and lipid peroxidation: first evidence

Arguably, the first demonstration of lipid peroxidation induced by Aβ employed electron paramagnetic resonance (EPR) methods (Butterfield et al., 1994). A lipid bilayer-soluble stearic acid spin label, which contains a sterically protected nitroxide moiety from which the EPR spectrum arises, was added to a gerbil synaptosomal preparation. Addition of Aβ to synaptosomes prepared from gerbils led to diminution of the intensity of this EPR spectrum. This phenomenon arises because a lipid centered

AD-related In Vivo or Ex Vivo Studies Involving Aβ and Lipid Peroxidation

Table 1 shows selected examples of AD-related in vivo or ex vivo studies involving Aβ from the Butterfield and Mattson laboratories. The main takeaways from these studies are:

  • a)

    Aβ42 and lipid peroxidation are intimately associated. This association makes sense, as this hydrophobic, oligomeric peptide intercalates into the lipid bilayer, in which there are copious amounts of labile lipid allylic H-atoms that can be extracted by a radical, leading to a cascade of events that culminates in

Redox Proteomics, Glucose Dysmetabolism, and AD

Redox proteomics is that branch of proteomics that is used to identify oxidatively modified proteins (Butterfield et al., 2012; Butterfield et al., 2014b; Butterfield and Boyd-Kimball, 2019). In essentially all oxidatively modified brain proteins, loss of activity of such proteins was observed. Loss of activity likely results from either oxidative modification of active site amino acids (e.g., cysteine; serine) and/or structural changes to oxidized proteins caused by oxidative modification of

Synergy of Studies between the Butterfield and Mattson Laboratories

The highly reactive and neurotoxic product of lipid peroxidation, HNE, by covalently binding to and modifying the structure and function of target proteins in brains of persons with AD, MCI, or animal models thereof, contributes significantly to the pathology, biochemistry, and clinical presentation of AD and its earlier stages, as described above. The Butterfield laboratory for the most part has focused on oxidative damage, with emphasis on lipid peroxidation and its sequale, in AD and MCI

Brief Reflections on Mark Mattson and His Outstanding Career

While he was at the University of Kentucky, Mark Mattson and I became very good friends and colleagues, and we remain so. We were both recruited to be part of the Sanders-Brown Center on Aging by the founder of this Center, Dr. William R. Markesbery, who also was a gifted Alzheimer disease researcher, clinician, and neuropathologist. Mark and I talked often of research ideas and plans, and we were separate Project Leaders together on two NIA-funded P01 Program Project Grants headed by Dr.

Acknowledgements

The author thanks the faculty of Sanders-Brown Center on Aging at the University of Kentucky for providing well-characterized specimens from AD, MCI, preclinical AD and brains and those from corresponding aged-matched controls, obtained at a quite short post-mortem interval for studies in our laboratory that are referenced in the current paper. The author thanks Dr. Xiaojia Ren for preparation of figures for this paper. This work was supported in part by grants from the National Institutes of

References (129)

  • D.A. Butterfield et al.

    beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer’s disease

    Biochem Biophys Res Commun

    (1994)
  • D.A. Butterfield et al.

    Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

    Free Radic Biol Med

    (2002)
  • D.A. Butterfield et al.

    Protein oxidation processes in aging brain

    Adv Cell Aging Gerontol

    (1997)
  • A. Castegna et al.

    Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1

    Free Radic Biol Med

    (2002)
  • A.D. Cohen et al.

    Early detection of Alzheimer’s disease using PiB and FDG PET

    Neurobiol Dis

    (2014)
  • F. Di Domenico et al.

    Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders

    Free Radic Biol Med

    (2017)
  • J. Drake et al.

    Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model

    Neurobiol Aging

    (2003)
  • H. Esterbauer et al.

    Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

    Free Radic Biol Med

    (1991)
  • S.A. Farr et al.

    Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease

    Free Radic Biol Med

    (2014)
  • A. Fiorini et al.

    Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study

    Free Radic Biol Med

    (2013)
  • B.A. Gordon et al.

    Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s disease: a longitudinal study

    Lancet Neurol

    (2018)
  • J. Kanski et al.

    Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer’s amyloid beta-peptide

    Free Radic Biol Med

    (2002)
  • D. Kapogiannis et al.

    Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer’s disease

    Lancet Neurol

    (2011)
  • T. Kato et al.

    Brain fluorodeoxyglucose (FDG) PET in dementia

    Ageing Res Rev

    (2016)
  • J.B. Owen et al.

    Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain

    Free Radic Biol Med

    (2010)
  • M.P. Mattson et al.

    Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States

    Cell Metab

    (2018)
  • M.P. Mattson et al.

    Neuronal and glial calcium signaling in Alzheimer’s disease

    Cell Calcium

    (2003)
  • W.R. Markesbery

    Oxidative stress hypothesis in Alzheimer’s disease

    Free Radic Biol Med

    (1997)
  • H. Mohmmad Abdul et al.

    Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer’s disease

    Biochim Biophys Acta

    (2005)
  • W.O. Opii et al.

    Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer’s disease

    Neurobiol Aging

    (2008)
  • M. Perluigi et al.

    In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress

    Neuroscience

    (2006)
  • C.B. Pocernich et al.

    Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease

    Neurochem Int

    (2001)
  • H.F. Poon et al.

    Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein

    Brain Res Mol Brain Res

    (2005)
  • H.F. Poon et al.

    Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders

    Neurochem Int

    (2005)
  • D. Pratico

    The neurobiology of isoprostanes and Alzheimer disease

    Biochim Biophys Acta

    (2010)
  • S.M. Raefsky et al.

    Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer’s disease

    Neurobiol Aging

    (2018)
  • S.M. Raefsky et al.

    Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance

    Free Radic Biol Med

    (2017)
  • T.T. Reed et al.

    Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD

    Brain Res

    (2009)
  • M. Aksenov et al.

    Oxidative modification of creatine kinase BB in Alzheimer’s disease brain

    J Neurochem

    (2000)
  • M.Y. Aksenov et al.

    Oxidative modification of glutamine synthetase by amyloid beta peptide

    Free Radic Res

    (1997)
  • C. Beaudoin-Chabot et al.

    Deuterated Polyunsaturated Fatty Acids Reduce Oxidative Stress and Extend the Lifespan of C. elegans

    Front Physiol

    (2019)
  • D. Boyd-Kimball et al.

    Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer’s disease

    Neurobiol Aging

    (2005)
  • D. Boyd-Kimball et al.

    Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease

    J Neurosci Res

    (2005)
  • D. Boyd-Kimball et al.

    Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach

    J Neurosci Res

    (2005)
  • R.K. Brown et al.

    Brain PET in suspected dementia: patterns of altered FDG metabolism

    Radiographics

    (2014)
  • A.J. Bruce-Keller et al.

    Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide

    J Neurochem

    (1998)
  • D.A. Butterfield

    Spin labeling in disease

  • D.A. Butterfield et al.

    Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease

    J Neurochem

    (2019)
  • D.A. Butterfield et al.

    Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death

    Neurobiol Aging

    (2002)
  • D.A. Butterfield et al.

    Mass spectrometry and redox proteomics: applications in disease

    Mass Spectrom Rev

    (2014)
  • Cited by (47)

    • The culprits of superoxide dismutase inactivation under size-dependent stress of ultrafine carbon black: Superoxide anion, genotoxicity and protein corona

      2023, Science of the Total Environment
      Citation Excerpt :

      The RLS spectra further proved that UFCB50nm with better dispersion can bind more SOD molecules, resulting in more serious damage to the protein structure. The structure and function of proteins are highly correlated (Butterfield, 2020). According to multiplex spectroscopy, exposure to UFCB with different particle sizes can cause differential structural changes in SOD.

    View all citing articles on Scopus
    View full text